Engineering the immune system to kill cancer cells

June 15, 2016
Electron microscopic image of a single human lymphocyte. Credit: Dr. Triche National Cancer Institute

In late 2015, former President Jimmy Carter announced that he was free of the metastatic melanoma that had spread to his liver and brain. In addition to surgery and radiation, Carter was treated with an immunotherapy drug, a new approach in cancer treatment that has a promising outlook.

A research team led by University of Notre Dame chemist Brian Baker is developing a new immunotherapy, a treatment that enhances in order to treat or prevent disease, as a means to more effectively target and kill cancer cells. According to Baker, "Immunotherapy is changing how cancer is treated."

T cells play a vital role in the immune system by attacking pathogens and . The team's study, recently published in the journal Structure, shows how T cell receptors can be engineered for specificity and function, and provides new methods for creating T cell receptors that are able to target specific cancer antigens, harmful substances that cause the body to produce antibodies.

The work of Baker's team is directed toward taking immunotherapy beyond the treatment Carter received. T cells that have been genetically altered to express engineered T cell receptors have been explored in clinical trials. Baker and his collaborators show how these receptors can be further engineered in order to recognize specific antigens on the surfaces of , thereby allowing cancer to be targeted with a heightened, more directed immune response with laser-like accuracy.

"Our study demonstrates new routes for custom designing functional T with optimal antigen recognition properties. This will help open the door for customized specificity in order to optimize T cell targeting and killing," said Baker.

Explore further: Cancer can be combated with reprogrammed macrophage cells

More information: Daniel T. Harris et al, An Engineered Switch in T Cell Receptor Specificity Leads to an Unusual but Functional Binding Geometry, Structure (2016). DOI: 10.1016/j.str.2016.04.011

Related Stories

Cancer can be combated with reprogrammed macrophage cells

May 20, 2016
Researchers at Karolinska Institutet have generated antibodies that reprogramme a type of macrophage cell in the tumour, making the immune system better able to recognise and kill tumour cells. The study, which is published ...

Genetically engineered immune cell therapy found to boost survival in mice with brain tumors

February 24, 2016
Nagoya University-led research team shows in mice the potential of a special immune cell that targets a key protein in tumor growth that helps stop brain cancer.

Presurgery chemotherapy may make advanced ovarian cancers responsive to immunotherapy

June 15, 2016
Bottom Line: Metastatic ovarian cancer patients treated with chemotherapy prior to surgery had altered immune cells in their tumors, and specific alterations identified suggest that immunotherapy given after chemotherapy ...

Targeting cancer with engineered T cells

April 20, 2016
Dr. Philip Greenberg, head of immunology and a member of the Clinical Research Division at Seattle's Fred Hutchinson Cancer Research Center and a leader in cancer immunology, will describe how he and colleagues are genetically ...

Finally, targeted therapies for triple-negative breast cancer

June 3, 2016
At the American Society for Clinical Oncology (ASCO) Annual Meeting 2016, researchers present results of three clinical trials using new targeted therapies against triple negative breast cancer (TNBC). Each therapy uses a ...

Research could expand engineered T-cell cancer treatment

April 21, 2016
Purdue University researchers may have figured out a way to call off a cancer cell assassin that sometimes goes rogue and assign it a larger tumor-specific "hit list."

Recommended for you

Gene immunotherapy protects against multiple sclerosis in mice

September 21, 2017
A potent and long-lasting gene immunotherapy approach prevents and reverses symptoms of multiple sclerosis in mice, according to a study published September 21st in the journal Molecular Therapy. Multiple sclerosis is an ...

New academic study reveals true extent of the link between hard water and eczema

September 21, 2017
Hard water damages our protective skin barrier and could contribute to the development of eczema, a new study has shown.

Exposure to pet and pest allergens during infancy linked to reduced asthma risk

September 19, 2017
Children exposed to high indoor levels of pet or pest allergens during infancy have a lower risk of developing asthma by 7 years of age, new research supported by the National Institutes of Health reveals. The findings, published ...

Cholesterol-like molecules switch off the engine in cancer-targeting 'Natural Killer' cells

September 18, 2017
Scientists have just discovered how the engine that powers cancer-killing cells functions. Crucially, their research also highlights how that engine is fuelled and that cholesterol-like molecules, called oxysterols, act as ...

MicroRNA helps cancer evade immune system

September 18, 2017
The immune system automatically destroys dysfunctional cells such as cancer cells, but cancerous tumors often survive nonetheless. A new study by Salk scientists shows one method by which fast-growing tumors evade anti-tumor ...

'Exciting' discovery on path to develop new type of vaccine to treat global viruses

September 15, 2017
Scientists at the University of Southampton have made a significant discovery in efforts to develop a vaccine against Zika, dengue and Hepatitis C viruses that affect millions of people around the world.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.